CO5580795A2 - Composicion para cateter y usos de las mismas - Google Patents
Composicion para cateter y usos de las mismasInfo
- Publication number
- CO5580795A2 CO5580795A2 CO04052140A CO04052140A CO5580795A2 CO 5580795 A2 CO5580795 A2 CO 5580795A2 CO 04052140 A CO04052140 A CO 04052140A CO 04052140 A CO04052140 A CO 04052140A CO 5580795 A2 CO5580795 A2 CO 5580795A2
- Authority
- CO
- Colombia
- Prior art keywords
- composition
- plasminogen activator
- catheter
- amount
- alcohol
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 8
- 102000001938 Plasminogen Activators Human genes 0.000 abstract 6
- 108010001014 Plasminogen Activators Proteins 0.000 abstract 6
- 229940127126 plasminogen activator Drugs 0.000 abstract 6
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 abstract 3
- 239000003527 fibrinolytic agent Substances 0.000 abstract 3
- 230000003480 fibrinolytic effect Effects 0.000 abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
- 102000009123 Fibrin Human genes 0.000 abstract 2
- 108010073385 Fibrin Proteins 0.000 abstract 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 abstract 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 abstract 2
- 108050006955 Tissue-type plasminogen activator Proteins 0.000 abstract 2
- 102100033571 Tissue-type plasminogen activator Human genes 0.000 abstract 2
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 abstract 2
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 abstract 2
- 230000003385 bacteriostatic effect Effects 0.000 abstract 2
- 229950003499 fibrin Drugs 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 229960005356 urokinase Drugs 0.000 abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 1
- 108010039185 Tenecteplase Proteins 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 abstract 1
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 abstract 1
- 239000008228 bacteriostatic water for injection Substances 0.000 abstract 1
- 235000019445 benzyl alcohol Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000002738 chelating agent Substances 0.000 abstract 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
- 229960000216 tenecteplase Drugs 0.000 abstract 1
- 229960000187 tissue plasminogen activator Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Enzymes And Modification Thereof (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33336901P | 2001-11-26 | 2001-11-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5580795A2 true CO5580795A2 (es) | 2005-11-30 |
Family
ID=23302492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO04052140A CO5580795A2 (es) | 2001-11-26 | 2004-06-03 | Composicion para cateter y usos de las mismas |
Country Status (28)
| Country | Link |
|---|---|
| US (3) | US20030206906A1 (OSRAM) |
| EP (1) | EP1455858A4 (OSRAM) |
| JP (1) | JP4458240B2 (OSRAM) |
| KR (2) | KR20040054803A (OSRAM) |
| CN (1) | CN100478027C (OSRAM) |
| AR (1) | AR037437A1 (OSRAM) |
| AU (2) | AU2002365408B2 (OSRAM) |
| BR (1) | BR0215098A (OSRAM) |
| CA (1) | CA2467645C (OSRAM) |
| CO (1) | CO5580795A2 (OSRAM) |
| EA (1) | EA007594B1 (OSRAM) |
| EC (2) | ECSDI045123S (OSRAM) |
| HR (1) | HRP20040502A2 (OSRAM) |
| HU (1) | HUP0600436A3 (OSRAM) |
| IL (2) | IL162083A0 (OSRAM) |
| IS (1) | IS7275A (OSRAM) |
| ME (1) | ME00015B (OSRAM) |
| MX (1) | MXPA04004948A (OSRAM) |
| MY (1) | MY140404A (OSRAM) |
| NO (1) | NO331700B1 (OSRAM) |
| NZ (1) | NZ533029A (OSRAM) |
| PL (1) | PL371760A1 (OSRAM) |
| RS (1) | RS46204A (OSRAM) |
| TW (1) | TWI262794B (OSRAM) |
| UA (1) | UA81235C2 (OSRAM) |
| UY (1) | UY27550A1 (OSRAM) |
| WO (1) | WO2003045466A2 (OSRAM) |
| ZA (1) | ZA200404024B (OSRAM) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1455858A4 (en) | 2001-11-26 | 2006-02-15 | Genentech Inc | CATHETER COMPOSITION AND ITS USES |
| US7128923B2 (en) * | 2003-03-31 | 2006-10-31 | Procyte Corporation | Preserved and stable compositions containing peptide copper complexes and method related thereto |
| DK2056865T3 (en) | 2006-08-28 | 2014-03-24 | Omnio Healer Ab | Hitherto unknown medicinal products for the prevention and treatment of gum disease, improvement of healing of gums in the gums and promotion of dental and oral health |
| CA2662101C (en) | 2006-08-28 | 2015-07-07 | Omnio Healer Ab | Candidates against infection |
| JP5871449B2 (ja) * | 2006-11-07 | 2016-03-01 | ジェネンテック， インコーポレイテッド | 組織プラスミノゲン活性化因子バリアントの使用 |
| RU2323001C1 (ru) * | 2007-05-30 | 2008-04-27 | Общество с ограниченной ответственностью "Научно-производственное предприятие "Техноген" | Фармацевтическая композиция, обладающая фибринолитическим действием |
| EP2160152B1 (en) | 2007-06-01 | 2016-07-27 | Arrow International, Inc. | Combined fibrinolytic and antimicrobial catheter and uses thereof |
| JP2010538092A (ja) * | 2007-09-07 | 2010-12-09 | ユナイテッド セラピューティクス コーポレーション | グラム陰性菌に対して選択的殺菌活性を有するバッファー溶液およびそれを使用する方法 |
| US9333280B2 (en) | 2009-02-25 | 2016-05-10 | Teleflex Medical Incorporated | Stabilized enzyme compositions |
| US8545459B2 (en) * | 2009-02-25 | 2013-10-01 | Teleflex Medical Incorporated | Stabilized enzyme compositions |
| EP2464406B1 (en) * | 2009-08-10 | 2016-10-26 | Proviflo, LLC | Catheter lock solutions utilizing tocopherol and mid-chain fatty acids |
| CN103083726A (zh) * | 2013-03-04 | 2013-05-08 | 昆明市第一人民医院 | 一种肝脏组织脱细胞液 |
| WO2016201269A2 (en) | 2015-06-11 | 2016-12-15 | Proviflo, Llc | Graft-port hemodialysis systems, devices and methods |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI831484A7 (fi) | 1982-05-05 | 1983-11-06 | Genentech Inc | Ihmiskudoksen plasminogeenien aktivaattori. |
| US5000185A (en) | 1986-02-28 | 1991-03-19 | Cardiovascular Imaging Systems, Inc. | Method for intravascular two-dimensional ultrasonography and recanalization |
| US5019096A (en) * | 1988-02-11 | 1991-05-28 | Trustees Of Columbia University In The City Of New York | Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same |
| US5270198A (en) | 1988-05-20 | 1993-12-14 | Genentech, Inc. | DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells |
| GB8820945D0 (en) * | 1988-09-07 | 1988-10-05 | Smith & Nephew | Medical articles |
| FR2661790B1 (fr) * | 1990-05-03 | 1995-08-25 | France Etat | Dispositif d'amplification tres large bande continu-hyperfrequences, notamment realisable en circuit integre. |
| AU7998091A (en) | 1990-05-17 | 1991-12-10 | Harbor Medical Devices, Inc. | Medical device polymer |
| US5399158A (en) | 1990-05-31 | 1995-03-21 | The United States Of America As Represented By The Secretary Of The Army | Method of lysing thrombi |
| US5363754A (en) * | 1991-09-03 | 1994-11-15 | Grainco Queensland Co-Operative Association Limited | Apparatus for preparing animal feedstuff from cotton seed |
| JPH05291891A (ja) * | 1992-02-14 | 1993-11-05 | Ricoh Co Ltd | 一次乱数パルス列発生回路装置 |
| DE69333127T2 (de) * | 1992-06-03 | 2004-05-06 | Genentech, Inc., South San Francisco | Varianten des Gewebeplasminogenaktivators mit verbesserter therapeutischer Wirkung |
| US5362754A (en) * | 1992-11-12 | 1994-11-08 | Univ. Of Tx Md Anderson Cancer Center | M-EDTA pharmaceutical preparations and uses thereof |
| US5688516A (en) * | 1992-11-12 | 1997-11-18 | Board Of Regents, The University Of Texas System | Non-glycopeptide antimicrobial agents in combination with an anticoagulant, an antithrombotic or a chelating agent, and their uses in, for example, the preparation of medical devices |
| US5849736A (en) | 1993-11-24 | 1998-12-15 | The Dupont Merck Pharmaceutical Company | Isoxazoline and isoxazole fibrinogen receptor antagonists |
| AU695853B2 (en) | 1993-11-24 | 1998-08-27 | Du Pont Pharmaceuticals Company | Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| US5885967A (en) * | 1994-03-04 | 1999-03-23 | Eli Lilly And Company | Antithrombotic agents |
| US5509896A (en) | 1994-09-09 | 1996-04-23 | Coraje, Inc. | Enhancement of thrombolysis with external ultrasound |
| AU716005B2 (en) * | 1995-06-07 | 2000-02-17 | Cook Medical Technologies Llc | Implantable medical device |
| US5772640A (en) * | 1996-01-05 | 1998-06-30 | The Trustees Of Columbia University Of The City Of New York | Triclosan-containing medical devices |
| US5932299A (en) * | 1996-04-23 | 1999-08-03 | Katoot; Mohammad W. | Method for modifying the surface of an object |
| US5840733A (en) * | 1996-07-01 | 1998-11-24 | Redcell, Canada, Inc. | Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes |
| US5837688A (en) * | 1996-11-27 | 1998-11-17 | Gelfand; Mathew I. | Use of thrombolytic reagents for prevention of vascular disease |
| GB9626795D0 (en) * | 1996-12-23 | 1997-02-12 | Geistlich Soehne Ag | Combating infection in delivery systems |
| WO1998028326A1 (en) | 1996-12-23 | 1998-07-02 | Biochem Pharma Inc. | Bicyclic thrombin inhibitors |
| US5981826A (en) * | 1997-05-05 | 1999-11-09 | Georgia Tech Research Corporation | Poly(vinyl alcohol) cryogel |
| JPH10328293A (ja) | 1997-06-04 | 1998-12-15 | Unitika Ltd | 医療用具及びその製造方法 |
| US6206914B1 (en) * | 1998-04-30 | 2001-03-27 | Medtronic, Inc. | Implantable system with drug-eluting cells for on-demand local drug delivery |
| US6166007A (en) * | 1998-07-02 | 2000-12-26 | Sodemann; Klaus | Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof |
| US6174537B1 (en) * | 1998-09-25 | 2001-01-16 | Becton, Dickinson And Company | Catheter flush solution and method for its use |
| JP2003526617A (ja) | 1999-03-11 | 2003-09-09 | デュポン ファーマシューティカルズ カンパニー | 種々の血栓塞栓性障害の予防および治療のための併用療法を提供する低分子量へパリンと血小板凝集阻害剤との相乗効果 |
| KR20020005614A (ko) | 1999-03-11 | 2002-01-17 | 블레어 큐. 퍼거슨 | Ｘａ 인자 저해제와 아스피린, 조직 플라스미노겐활성화인자(ＴＰＡ), ＧＰⅡｂ／Ⅲａ 길항제, 저분자량헤파린 또는 헤파린의 병용에 의한 혈전증 치료 |
| CA2302720C (en) | 1999-03-29 | 2009-07-14 | Ed Geistlich Sohne Ag Fur Chemische Industrie | Anticoagulant/sterilizing compositions and methods |
| US6187768B1 (en) * | 1999-06-01 | 2001-02-13 | Becton, Dickinson And Company | Kit for flushing medical devices and method of preparation |
| EP1060747A3 (en) * | 1999-06-16 | 2001-12-05 | New York Blood Center, Inc. | Fibrin(ogen) degradation and clot lysis by fibrinolytic metalloproteinase |
| US6592564B2 (en) * | 1999-07-23 | 2003-07-15 | Vasca, Inc. | Methods and kits for locking and disinfecting implanted catheters |
| US6350251B1 (en) | 2000-01-18 | 2002-02-26 | Biolink Corporation | Biocidal locks |
| US20010031981A1 (en) | 2000-03-31 | 2001-10-18 | Evans Michael A. | Method and device for locating guidewire and treating chronic total occlusions |
| ES2306716T3 (es) | 2000-05-10 | 2008-11-16 | Ash Access Technology, Inc. | Disolucion de sellado de cateteres que incluye un foto-oxidante. |
| US6772640B1 (en) * | 2000-10-10 | 2004-08-10 | Mks Instruments, Inc. | Multi-temperature heater for use with pressure transducers |
| US20050215978A1 (en) | 2001-05-25 | 2005-09-29 | Ash Stephen R | Method of enhancing catheter patency using a citrate salt catheter lock solution |
| EP1455858A4 (en) | 2001-11-26 | 2006-02-15 | Genentech Inc | CATHETER COMPOSITION AND ITS USES |
| US20070014779A1 (en) | 2002-11-14 | 2007-01-18 | Genentech, Inc. | Plasminogen activator variant formulations |
| DE60311958T2 (de) | 2003-02-03 | 2007-11-08 | Polaschegg, Hans-Dietrich, Dr. | Zusammensetzung zur Prävention von Infektionen durch subkutane Prothesen |
| US7696182B2 (en) | 2004-11-02 | 2010-04-13 | Nd Partners, Llc | Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin |
| US7749529B2 (en) | 2005-02-08 | 2010-07-06 | Ash Access Technology, Inc. | Catheter lock solution comprising citrate and a paraben |
| JP5871449B2 (ja) | 2006-11-07 | 2016-03-01 | ジェネンテック， インコーポレイテッド | 組織プラスミノゲン活性化因子バリアントの使用 |
-
2002
- 2002-11-25 EP EP02791318A patent/EP1455858A4/en not_active Withdrawn
- 2002-11-25 BR BR0215098-0A patent/BR0215098A/pt not_active IP Right Cessation
- 2002-11-25 HR HRP20040502 patent/HRP20040502A2/hr not_active Application Discontinuation
- 2002-11-25 EA EA200400712A patent/EA007594B1/ru not_active IP Right Cessation
- 2002-11-25 NZ NZ533029A patent/NZ533029A/en not_active IP Right Cessation
- 2002-11-25 KR KR10-2004-7007931A patent/KR20040054803A/ko not_active Abandoned
- 2002-11-25 US US10/304,666 patent/US20030206906A1/en not_active Abandoned
- 2002-11-25 WO PCT/US2002/037878 patent/WO2003045466A2/en not_active Ceased
- 2002-11-25 JP JP2003546965A patent/JP4458240B2/ja not_active Expired - Lifetime
- 2002-11-25 AU AU2002365408A patent/AU2002365408B2/en not_active Ceased
- 2002-11-25 RS YU46204A patent/RS46204A/sr unknown
- 2002-11-25 KR KR1020107019474A patent/KR20100102745A/ko not_active Ceased
- 2002-11-25 UA UA20040605026A patent/UA81235C2/uk unknown
- 2002-11-25 PL PL02371760A patent/PL371760A1/xx unknown
- 2002-11-25 MX MXPA04004948A patent/MXPA04004948A/es active IP Right Grant
- 2002-11-25 HU HU0600436A patent/HUP0600436A3/hu unknown
- 2002-11-25 ME MEP-2008-80A patent/ME00015B/me unknown
- 2002-11-25 IL IL16208302A patent/IL162083A0/xx unknown
- 2002-11-25 CA CA2467645A patent/CA2467645C/en not_active Expired - Lifetime
- 2002-11-25 CN CNB028275578A patent/CN100478027C/zh not_active Expired - Fee Related
- 2002-11-26 UY UY27550A patent/UY27550A1/es not_active Application Discontinuation
- 2002-11-26 MY MYPI20024411A patent/MY140404A/en unknown
- 2002-11-26 AR ARP020104542A patent/AR037437A1/es unknown
- 2002-11-26 TW TW091134325A patent/TWI262794B/zh not_active IP Right Cessation
-
2004
- 2004-05-20 IL IL162083A patent/IL162083A/en not_active IP Right Cessation
- 2004-05-21 IS IS7275A patent/IS7275A/is unknown
- 2004-05-24 ZA ZA2004/04024A patent/ZA200404024B/en unknown
- 2004-05-26 EC EC2004005123F patent/ECSDI045123S/es unknown
- 2004-05-26 EC EC2004005123A patent/ECSP045123A/es unknown
- 2004-06-03 CO CO04052140A patent/CO5580795A2/es not_active Application Discontinuation
- 2004-06-25 NO NO20042693A patent/NO331700B1/no not_active IP Right Cessation
-
2006
- 2006-06-23 US US11/426,263 patent/US7829082B2/en not_active Expired - Lifetime
- 2006-06-23 US US11/426,283 patent/US20060257390A1/en not_active Abandoned
-
2008
- 2008-07-15 AU AU2008203131A patent/AU2008203131A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5580795A2 (es) | Composicion para cateter y usos de las mismas | |
| ES2065294B1 (es) | Composiciones acuosas oburadoras de fibrina y metodo para prepararlas. | |
| AR092919A2 (es) | Composicion farmaceutica liquida | |
| ATE409222T1 (de) | Verfahren zur herstellung einer reversibel inaktiven, angesäuerten plasminzusammensetzung | |
| ES2166783T3 (es) | Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii. | |
| ES8505405A1 (es) | Un procedimiento para producir un activador de plasminogeno purificado. | |
| FR2591485B1 (fr) | Compositions stabilisees contenant l'activateur du plasminogene du tissu humain. | |
| DK36991A (da) | Vaevsplasminoaktivator-(t-pa)-variant med zymogene eller fibrinspecifikke eller plasmakoagel-specifikke egenskaber, fremgangsmaade til fremstilling deraf, dna-sekvens, som koder for varianten, replicerbar udtrykkelsesvektor for denne og vaertsceller transformeret med vektoren | |
| SE8701921D0 (sv) | Ny farmaceutisk anvendning | |
| MX9701514A (es) | Limpieza, desinfeccion y preparacion de lentes de contacto. | |
| MX169931B (es) | Procedimiento para determinar la catividad de serinproteasas inhibidores de serinproteasas | |
| ES511604A0 (es) | "un procedimiento para la obtencion de un principio activo fibrinolitico vasal o vascular, quimicamente denominable "enzima angioquinasa"". | |
| DE50212548D1 (de) | Nicht-neurotoxische plasminogen aktivierende faktoren zur behandlung von schlaganfall | |
| ES2163528T3 (es) | Una solucion acuosa para infusion, estable al almacenamiento, que contiene un inhibidor de trombina. | |
| PE43995A1 (es) | Procedimiento para la prevencion de la degradacion de la proteina c | |
| DK0517756T3 (da) | Vævs-plasminogenaktivator med fibrinspecifikke egenskaber | |
| ES2061982T5 (es) | Activador de plasminogeno y agente trombolitico. | |
| EA199800755A1 (ru) | Композиции, содержащие ингибитор вич протеазы, а именно as vx 478, и водорастворимое соединение витамина e, а именно витамин e-tpgs | |
| MX9306503A (es) | Metodo de desinfeccion de lentes de contacto y de preservacion de una solucion para el cuidado de un lente de contacto. | |
| KR950031102A (ko) | 지속성 혈전치료제인 피브린분해효소의 4-(n,n,n-트리메틸아미노)-신나모일 유도체 및 그 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |